Galapagos | GLPG - Ebitda

Stock Price
29.16
Daily Change
0.26 0.90%
Monthly
6.81%
Yearly
32.43%
Q1 Forecast
27.75

Galapagos reported EUR-158.71M in EBITDA for its fiscal quarter ending in March of 2025.





Ebitda Change Date
argenx SE USD 288.02M 84.53M Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
Genmab DKK 477M 101M Sep/2025
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Incyte USD 581.52M 358.87M Jun/2025
Merck EUR 1.46B 45M Jun/2025
Neurocrine Biosciences USD 246.7M 93.8M Sep/2025
Novartis USD 5.88B 290M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
UCB EUR 1.03B 334M Jun/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025